JC
Schedule 13G filing
JPMORGAN CHASE & CO disclosed a 5.2% stake in Neurocrine Biosciences Inc (NBIX)
JPMORGAN CHASE & CO reported owning 5.2% of Neurocrine Biosciences Inc (NBIX) (5,300,390 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13G
More NBIX insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.